Press Releases
A love for complexity ADC drug development
Antibody-drug conjugates (ADCs) are a promising cancer therapy, delivering potent drugs directly to tumor cells. In this article, Yoonjin Kwon, a Lead Scientist in ADC Analytical Method Development, shares her insights on the challenges and emerging trends in ADC development, drawing from her extensive experience.
Antibody-drug conjugates (ADCs) are a promising cancer therapy, delivering potent drugs directly to tumor cells. In this article, Yoonjin Kwon, a Lead Scientist in ADC Analytical Method Development, shares her insights on the challenges and emerging trends in ADC development, drawing from her extensive experience.